A New Class of Nitric Oxide Donors

Paper by RAS Academician S. M. Aldoshin^a, Doctor of Science (Chemistry) N. A. Sanina^a,
RAS Academician M. I. Davydov^b, and RAS Academician E. I. Chazov^c*

^a Institute of Problems of Chemical Physics, Russian Academy of Sciences, Chernogolovka, Moscow oblast, Russia

^b Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

^c Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation, Moscow, Russia

e-mail: smaldoshin@presidium.ras.ru, sanina@icp.ac.ru, ronc@list.ru, cclibr@cardio.ru

Received January 25, 2016

Abstract—This article deals with a new class of nitric oxide donors—safe medications for the treatment of
socially significant diseases. This complex work has been performed in collaboration with a number of RAS
institutes, the Russian Cardiology Research and Production Complex, and the Blokhin Russian Cancer
Research Center.

Keywords: nitric oxide donors, endothelial cells, NO therapy, nitrosyl nonheme proteins.

DOI: 10.1134/S1019331616030096

Pleiades Publishing home page | journal home page | top

If you have any problems with this server, contact webmaster.